medigraphic.com
Instituto Nacional de Neurología y Neurocirugía

2018, Number 3

<< Back Next >>

Arch Neurocien 2018; 23 (3)

Executive function and therapeutic adherence in type 2 diabetes mellitus

Cerezo-Huerta K, Yáñez-Téllez G, Aguilar-Salinas CA

Language: Spanish
References: 30
Page: 42-53
PDF size: 456.68 Kb.


ABSTRACT

Introduction: Cognitive impairment is associated with type 2 diabetes mellitus (T2DM), however there’s no agreement regarding the interaction between the therapeutic adherence’s factors (TAF) with executive function (EF).
Objective: to estimate the influence of TAF on EF’s performance in diabetic patients.
Method: A case-control study on outpatients with T2DM; matched by sex, age and scholarship with healthy controls. Data were obtained from physiological, psychological and neuropsychological evaluation.
Results: A total of 95 diabetic patients and 95 healthy controls with a mean age of 55.51 (diabetics) and 55.45 (controls) and scholarship of 11.73 (diabetics) and 11.64 (controls) were enrolled. The FE’s performance in both groups was in the average range; however, in the group of diabetics the performance was lower in memory tasks (short-term visual memory -P .039- and verbal working memory -P .001-) and mental planning (P .033). The TAF was associated with demographic and clinical indicators.
Discussion and conclusions: There’re specific difficulties in some of EF’s domains in patients with T2DM that are influenced by demographic and clinic factors. It is recommended to make periodic evaluations in high-level cognitive skills in the diabetic patient to propose psychoeducational alternatives to increase self-care in these patients.


REFERENCES

  1. American Diabetes Association. 11. Older adults: standard of medical care in diabetes-2018. (2018). Diabetes Care, 41 (1): S119-S125.

  2. Organización Mundial de la Salud. 10 datos sobre la diabetes. (2018). [consultada el 9 de julio de 2018] Disponible en: http://www.who.int/features/factfiles/diabetes/es/

  3. Organización Panamericana de la Salud. Adherencia a los tratamientos a largo plazo: pruebas para la acción. 2004. (2018). [consultada el 9 de julio de 2018] Disponible en: http://www.farmacologia.hc.edu.uy/images/WHOAdherence- Long-Term-Therapies-Spa-2003.pdf

  4. Luchsinger J, Reitz C, Patel B, Tang M, Manly J, Mayeux R. Relation of diabetes to mild cognitive impairment. Arch Neurol 2007; 64: 570-575.

  5. Pruzin J, Nelson P, Abnert E, Arvanitakis Z. Invited Review: Relationship of type 2 diabetes to human brain pathology. Neuropathol Appl Neurobiol; 2018. DOI:10.1111/nan.12476.

  6. Milne N, Bucks R, Davis W, Davis T, Pierson R, et al. Hippocampal atrophy, asymmetry, and cognition in type 2 diabetes mellitus. Brain Behav 2017; 8(1):e00741. DOI: 10.1002/brb3.741.

  7. Redondo M, Beltrán-Brotóns J, Reales J, Ballesteros S. Executive functions in patients with Alzheimer’s disease, type 2 diabetes mellitus patients and cognitively healthy older adults. Exp Gerontol 2016; 83: 47-55.

  8. Anderson V, Jacobs R, Anderson P. Executive Functions and the Frontal Lobes: a life span perspective. 2008 New York: Taylor and Francis Group.

  9. Mansur R, Lee Y, Zhou A, Carmona N, Cha D. et. al. Determinants of cognitive function in individuals with type 2 diabetes mellitus: a meta-analysis. Ann Clin Psychiatry 2018;30(1): 38-50.

  10. Tomli A, Sinclair A. The influence of cognition on self-management of type 2 diabetes in older people. Psychol Res Behav Manag 2016; 9:7-20.

  11. Tran D, Baxter J, Hamman R, Grigsby J. Impairment of executive cognitive control in type 2 diabetes, and its effects on health-related behavior and use of health services. J Behav Med 2014; 37(3): 414-422.

  12. Cukierman T, Gerstein H, Williamson J. Cognitive decline and dementia in diabetes – systematic overview of prospective observational studies. Diabetologia 2005; 48(12): 2460-2469.

  13. Cukierman T. Diabetes, dysglycemia and cognitive dysfunction. Diabetes Metab Res Rev 2014; 30: 341-345.

  14. Wechsler Memory Scale -WMS-III-. 1998. London: The Psychological Corporation.

  15. Golden, Ch. Stroop: test de colores y palabras. 1994. Madrid: TEA Ediciones.

  16. Culbertson W, Zillmer E. Tower of London-Drexel University. (2a ed.). Canada: Multi-Health Systems (2005).

  17. Heaton R, Chelune G, Talley J, Kay G. Curtiss G. (1997). Test de clasificación de tarjetas de Wisconsin. Madrid: TEA Ediciones.

  18. Bechara A. Iowa gambling task: professional manual. U.S.A: Psychological Assessment Resources (2007).

  19. Babor T, Higgings-Biddle J, Saunders J, Monteiro M. Cuestionario de identificación de los trastornos debidos al consumo de alcohol: pautas para su utilización en atención primaria. [consultada el 9 de julio de 2018] Disponible en: http://www.who.int/substance_abuse/activities/en/AUDITmanualSpanish.pdf

  20. Fagerström K, Schneider N. Measuring nicotine dependence: a review of the Fagerström tolerance questionnaire. Journal of Behavior Medicine 1989; 12: 159-182.

  21. Zigmond A, Snaith R. The hospital anxiety and depression scale. Acta Psychiart Scand 1983; 67: 361-370.

  22. Aberle I, Kliegel M, Zimprich D. Cognitive development in young-old type 2 diabetes patients: a longitudinal analysis from the “interdisciplinary longitudinal study of aging”. Current Psychol 2008; 27, 6-15.

  23. Marseglia A, Fratiglioni L, Laukka E, Santoni G, Pedersen N, et. al. Early cognitive deficits in type 2 diabetes: a population-based study. J Alzheimers Dis 2016; 53(3): 1069-1078.

  24. Zaninotto P, Batty D, Allerhand M. Deary I. Cognitive function trajectories and their determinants in older people: 8 years of follow-up in the English Longitudinal Study of Ageing. J Epidemiol Community Health 2018; 1: 1-10.

  25. Zihl J, Schaaf L, Zillmer E. The relationship between adult neuropsychological profiles and diabetic patient´s glycemic control. Appl Neuropsychol 2010; 17: 44-51.

  26. Gao Y, Xiao Y, Miao R, Zhao J, Zhang W, et al. The characteristics of cognitive function in type 2 diabetes mellitus. Diabetes Res Clin Pract 2015; 109(2): 299-305.

  27. Vincent C, Hall P. Executive function in adults with type 2 diabetes: a meta-analiytic review. Psychosom Med 2015; 77(6): 631-642.

  28. Primozic S, Tavcar R, Avbelij M, Dernovsek M, Oblak M. Specific cognitive abilities are associated with diabetes selfmanagement behavior among patients with type 2 diabetes. Diabetes Res Clin Pract 2011; 95(1): 48-54.

  29. Petrova M, Prokopenko S, Pronina E, Mozheyko E. Diabetes type 2, hypertension and cognitive dysfunction in middle age women. J Neurol Sci 2010; 299(1-2): 39-41.

  30. Geobers B, Uiters E, Reijneveld S, Jansen C, Almansa J, et.al. Health literacy among older adults is associated with their 10-years’ cognitive functioning and decline – The Doetinchem cohort study. BMC Geriatr 2018; 18(77): 2-7.




2020     |     www.medigraphic.com